Updated: February 26, 2021 5:25:46 am
The Supreme Court has rejected a plea seeking extension of time till March 31 to complete the one-time settlement (OTS) of dues owed by Gujarat-based Sterling Biotech Limited (SBL) — which is facing a money laundering probe — to a consortium of banks.
A Bench of Justices R F Nariman and B R Gavai dismissed the application filed by SBL-owned Richmond Investments Ltd, seeking the relief.
Richmond, in its application, had sought the extra time to save SBL from impending liquidation saying that if liquidation happens, it “will affect the pharmaceutical industry as 60 per cent of capsules sold in the country are manufactured from gelatin produced by the company which will have devastating disruption during this pandemic”.
The plea contended that several thousand employees would lose their jobs if the liquidation goes through.
In an additional affidavit, the company said that SBL promoters, Nitin Sandesara, Chetankumar Sandesara, Dipti Chetan Sandesara and Hiteshkumar Patel “are facing a frivolous prosecution including under PMLA (Prevention of Money Laundering Act) for alleged default in payment towards the loan accounts.”
📣 The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines
- The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards.